Repligen (RGEN) Non Operating Income (2012 - 2026)
Repligen's (RGEN) quarterly Non Operating Income came in at -$14.2 million in Q1 2026, down 1137.95% year-on-year from $1.4 million in Q1 2025, and down 1237.99% on a QoQ basis from $1.2 million in Q4 2025.
Repligen (RGEN) Non Operating Income (2012 - 2026) Analysis & Trends
Repligen (RGEN) has 12 years of Non Operating Income data on file, last reported at -$14.2 million in Q1 2026.
- On a quarterly basis, Non Operating Income fell 1137.95% year-over-year to -$14.2 million in Q1 2026; TTM through Mar 2026 was -$8.3 million, a 187.56% decrease from a year earlier, with the FY2025 full-year figure at $7.2 million, down 10.68% from the prior year.
- Non Operating Income for Q1 2026 stood at -$14.2 million, down from $1.2 million in the prior quarter.
- Over the last five years, Non Operating Income for RGEN reached as high as $6.7 million in Q3 2023 and fell as low as -$14.2 million in Q1 2026.
- Historically, Non Operating Income has averaged $270647.1 across 5 years, with a median of $1.2 million in 2025.
- Across the five-year window, Non Operating Income jumped 2581.82% in 2025 and tumbled 1137.95% in 2026, its largest moves.
- Year by year, Non Operating Income stood at $4.1 million in 2022, then sank by 293.01% to -$8.0 million in 2023, then jumped by 73.69% to -$2.1 million in 2024, then soared by 159.09% to $1.2 million in 2025, then slumped by 1237.99% to -$14.2 million in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were -$14.2 million in Q1 2026, $1.2 million in Q4 2025, and $287000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 82.70 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -131.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 12.29 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -12.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 3.50 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -62.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 6.93 Mn |
| 10 | Repligen | 7.75 Bn | 6.77 Bn | 108.28 Mn | -14.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.17 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 287,000.00 |
| Jun 30, 2025 | 4.32 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | -2.11 Mn |
| Sep 30, 2024 | 6.68 Mn |
| Jun 30, 2024 | 3.56 Mn |
| Mar 31, 2024 | -55,000.00 |
| Dec 31, 2023 | -8.01 Mn |
| Sep 30, 2023 | 6.69 Mn |
| Jun 30, 2023 | 5.62 Mn |
| Mar 31, 2023 | 4.70 Mn |
| Dec 31, 2022 | 4.15 Mn |
| Sep 30, 2022 | -5.20 Mn |
| Jun 30, 2022 | -3.41 Mn |
| Mar 31, 2022 | -1.07 Mn |
| Dec 31, 2021 | -2.58 Mn |
| Sep 30, 2021 | -3.96 Mn |
| Jun 30, 2021 | -3.88 Mn |